Xth Eurasian Hematology-Oncology Congress

http://www.ehog.net/

 

Management of ALK+ NSCLC Through First and Subsequent Lines of Therapy: 1st vs. 2nd Generation ALK TKIs

0 views
March 18, 2021
Comments 0
Login to view comments. Click here to Login